Page last updated: 2024-08-22

hyaluronoglucosaminidase and Brill-Symmers Disease

hyaluronoglucosaminidase has been researched along with Brill-Symmers Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jackisch, C; Shpilberg, O	1

Trials

1 trial(s) available for hyaluronoglucosaminidase and Brill-Symmers Disease

Article	Year
Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase. British journal of cancer, 2013, Sep-17, Volume: 109, Issue:6 Topics: Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Female; Humans; Hyaluronoglucosaminidase; Injections, Subcutaneous; Lymphoma, Follicular; Male; Recombinant Proteins; Rituximab; Trastuzumab	2013

Article

Year

Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase.

British journal of cancer, 2013, Sep-17, Volume: 109, Issue:6

Topics: Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Female; Humans; Hyaluronoglucosaminidase; Injections, Subcutaneous; Lymphoma, Follicular; Male; Recombinant Proteins; Rituximab; Trastuzumab

2013